EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol reduces neuropathic pain and cognitive impairments through activation of spinal PPARγ

Ana Mara Islas-Espinoza, Itzel I Ramos-Rodríguez, María J Escoto-Rosales, Juan M Pizaña-Encarnación, Diana K Morales-Galindo, Nadia L Caram-Salas, Myrna Déciga-Campos, Erick J Rodríguez-Palma, Vinicio Granados-Soto

The Journal of Pain · 2025-05 · 30 · 105378

DOI: 10.1016/j.jpain.2025.105378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pain, 2025-05. Verfasst von Ana Mara Islas-Espinoza und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology of Pain Laboratory, Departamento de Farmacobiología, Cinvestav, South Campus, Mexico City, Mexico. Hauptthemen laut MEDLINE: Cannabidiol, PPAR gamma, Neuralgia, Cognitive Dysfunction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study was to evaluate the participation of spinal peroxisome proliferator-activated receptor gamma (PPARγ) in the antiallodynic effect of cannabidiol, the expression of PPARγ in sites relevant to the spinal nociceptive processing, and the effect of this cannabinoid on cognitive deficits induced by neuropathic pain in female mice. Either acute or repeated treatment with cannabidiol reduced tactile allodynia and spontaneous pain (flinching) in female neuropathic mice. Cannabidiol induced a greater effect in female mice. Pioglitazone partially reduced tactile allodynia, and this effect was fully blocked by the PPARγ antagonist GW9662. Likewise, intrathecal injection of cannabidiol reduced tactile allodynia, while PPARγ antagonist GW9662 or 5-HT1A receptor antagonist WAY-100635, but not the PPARα antagonist GW6479, partially prevented this effect. GW9662 and WAY-100635 administrated per se did not modify tactile allodynia in neuropathic female mice. Co-administration of GW9662 and WAY-100635 fully prevented the antiallodynic effect of cannabidiol in mice. Nerve injury up-regulated PPARγ expression at the spinal cord and dorsal root ganglia, while cannabidiol further enhanced nerve injury-induced up-regulation of PPARγ expression in both tissues. Repeated intrathecal injection of cannabidiol reduced tactile allodynia and several pain makers (ERK, p-ERK, p38MAPK and p-p38MAPK). In addition, this treatment restored nerve injury-induced interleukin-10 down-regulation and increased PPARγ expression at the spinal cord. Repeated treatment with cannabidiol also improved nerve injury-induced cognitive impairment in mice. These results provide compelling evidence for the involvement of PPARγ in the antiallodynic effect of cannabidiol in mice and highlight its multifaceted therapeutic potential in neuropathic pain management and its comorbidities. PERSPECTIVE: The present study reveals cannabidiol's dual effects in female mice by reducing neuropathic pain through spinal PPARγ and 5-HT1A receptor activation and ameliorating nerve injury-induced cognitive impairment. These findings may assist clinicians seeking new therapeutic approaches for managing neuropathic pain and its associated cognitive deficits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolPPAR gammaNeuralgiaCognitive DysfunctionHyperalgesiaSpinal CordAnimalsFemaleMiceDisease Models, AnimalAnilidesPyridines

Stichwörter der Autor:innen

CannabidiolCognitive impairmentMechanism of actionNeuropathic painPPARγ

Substanzen

CannabidiolPPAR gamma2-chloro-5-nitrobenzanilideAnilidesPyridinesPparg protein, mouse

Autor:innen und Institutionen

  • Neurobiology of Pain Laboratory, Departamento de Farmacobiología, Cinvestav, South Campus, Mexico City, Mexico.
  • División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco, Villahermosa, Tabasco, Mexico.
  • Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.
  • Investigadora por México, Consejo Nacional de Humanidades, Ciencias y Tecnologías (Conahcyt), Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California, Mexico; Departamento de Innovación B…
  • Neurobiology of Pain Laboratory, Departamento de Farmacobiología, Cinvestav, South Campus, Mexico City, Mexico. Electronic address: vgranados@cinvestav.mx.

Förderung

  • Consejo Nacional de Humanidades, Ciencias y Tecnologías

Zitieren

APA

Islas-Espinoza, A. M., Ramos-Rodríguez, I. I., Escoto-Rosales, M. J., Pizaña-Encarnación, J. M., Morales-Galindo, D. K., Caram-Salas, N. L., Déciga-Campos, M., Rodríguez-Palma, E. J., & Granados-Soto, V. (2025). Cannabidiol reduces neuropathic pain and cognitive impairments through activation of spinal PPARγ. The Journal of Pain, 30, 105378. https://doi.org/10.1016/j.jpain.2025.105378

Vancouver

Islas-Espinoza AM, Ramos-Rodríguez II, Escoto-Rosales MJ, Pizaña-Encarnación JM, Morales-Galindo DK, Caram-Salas NL, et al. Cannabidiol reduces neuropathic pain and cognitive impairments through activation of spinal PPARγ. The Journal of Pain. 2025;30:105378. doi:10.1016/j.jpain.2025.105378

BibTeX
@article{IslasEspinoza2025,
  author = {Islas-Espinoza, Ana Mara and Ramos-Rodríguez, Itzel I and Escoto-Rosales, María J and Pizaña-Encarnación, Juan M and Morales-Galindo, Diana K and Caram-Salas, Nadia L and Déciga-Campos, Myrna and Rodríguez-Palma, Erick J and Granados-Soto, Vinicio},
  title = {Cannabidiol reduces neuropathic pain and cognitive impairments through activation of spinal PPARγ},
  journal = {The Journal of Pain},
  year = {2025},
  volume = {30},
  pages = {105378},
  doi = {10.1016/j.jpain.2025.105378}
}
Kostenlos starten →